Agilent | A - Cost Of Sales


Agilent reported $845M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Agilent USD 845M 7M Mar/2026
Align Technology USD 303.5M 60.47M Mar/2026
Bio Techne USD 103.13M 1.47M Mar/2026
Bio-Rad Laboratories USD 348M 38.4M Dec/2025
Bruker USD 443.6M 84.4M Mar/2026
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Danaher USD 2.36B 512M Mar/2026
Dentsply International USD 453M 65M Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Henry Schein USD 2.3B 145M Mar/2026
Illumina USD 370M 30M Mar/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Laboratory Of America USD 2.6B 4.2M Mar/2026
Mettler Toledo International USD 410.92M 63.05M Mar/2026
Myriad Genetics USD 63M 1.1M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Quidel USD -79.5M 528.3M Mar/2026
Repligen USD 85.97M 8.11M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Waters USD 725M 350.06M Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026